Top

Reactions Weekly

Published in:

01-05-2022 | Splenectomy | Case report

Camrelizumab/sorafenib

Hand-foot syndrome following off-label use : case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Pan D, et al. Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review. World Journal of Clinical Cases 10: 2818-2828, No. 9, 26 Mar 2022. Available from: URL: http://doi.org/10.12998/wjcc.v10.i9.2818

Title: Camrelizumab/sorafenib
Hand-foot syndrome following off-label use : case report
Publication date: 01-05-2022
Publisher: Springer International Publishing
Keywords: Splenectomy
Splenectomy
Thyroidectomy
Thyroidectomy
Sorafenib
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-14533-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Camrelizumab/sorafenib

Hand-foot syndrome following off-label use : case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Adalimumab/golimumab/infliximab

Multiple drugs

Carbon-dioxide

Adalimumab/methotrexate

Amlodipine/isosorbide-mononitrate

Enoxaparin-sodium